Abstract
Pharmacovigilance targets the safety of medicine. The collection and clinical risk assessment of post-marketing safety data are critical for evaluating and characterizing the safety profile of medicines. The changing climate requires Market Authorization Holders and Health Systems to take a more proactive approach in dealing with drug safety and pharmacovigilance. Community pharmacists are the most accessible of health professionals and play a crucial role in maintaining health systems’ rational and safe use of medications since they are drug experts who are specifically trained in this field. The development and use of pharmacovigilance systems with integration to electronic medical records, electronic health records, and clinical data management systems hold promise as a tool for enabling community pharmacists to detect early drug safety detections and saving time, reporting high-quality data, assisting in safety decision, and increasing safer and more efficacious use of medicines. Careful planning and ongoing, critical evaluation of processes are central to the successful implementation of major health information technology in community pharmacies.